Medicare & Medicaid

CMS will release traditional and digital advertisements and educational materials directed to those with high uninsured rates.

Clover is discontinuing its current co-branding arrangement with Walmart to offer MA plans in Georgia.

Physician fee schedule payments fail to keep up with inflation and threaten patient access to critical treatments, ACS says.

This week's top stories include the VA flagging unreliable IT infrastructure cost estimates for its EHR modernization program, a new Alzheimer's drug that could strain Medicaid budgets, and Amazon using radar for monitoring sleep.

Since February 15, 1.5 million Americans have signed up on HealthCare.gov, with 600,000 more enrolling through state-based marketplaces.

Medicaid will see increased costs through beneficiaries’ direct payment of the drug, plus potentially higher Medicare premium payments.

Proposed rule asks for feedback on data collection on LGBTQ+, race and ethnicity, rural populations and more.

CMS is moving forward with the next evolution of the Quality Payment Program by proposing its first seven MIPS Value Pathways. 

The analysis will target aducanumab, recently approved by the FDA, as well as any future monoclonal antibodies that treat Alzheimer’s.

Pharmaceutical companies raised compensation for their top executives while steadily increasing drug prices, the committee found.